Among the multilateral development banks, the Asian Development Bank (ADB) stands out for its strong financial support for COVID-19 response relative to its overall lending volume. While ADB has proven to be responsive to government’s general financing needs during the crisis, has ADB’s performance matched the specific needs of the governments and populations facing the crisis in the region? Have the greater volumes of support actually targeted the people, places, and sectors that most need it? In a new policy paper, we tackle these questions.
CGD Policy Blogs
COVID-19 and the economic crisis it unleashed have spurred unprecedented action from governments and international institutions. Multilateral development banks (MDBs) like the Asian Development Bank (ADB) swiftly committed resources to COVID-19 response and recovery efforts in 2020 and 2021, including a $20 billion countercyclical support facility and a $9 billion facility specifically for COVID-19 vaccine procurement and vaccination program implementation.